Our experiments, therefore, aimed to characterize specific gene expression pattern of angiosarcomas with TP53 LOF and represents a model that could be further used for pre-clinical drug testing and development, as well as imaging studies with novel agents. The gene discussed is TP53; the disease is angiosarcoma.